SwanBio Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 32

Employees

  • Latest Deal Type
  • M&A

SwanBio Therapeutics General Information

Description

Developer of a therapeutic technology designed to deliver dramatic clinical efficacy for the treatment of neurological diseases. The company's technology focuses on the development and commercialization of genetically-defined therapies for the treatment of neuro disorders, enabling healthcare organizations to get the apparatus for the treatment of AMN and other diseases.

Contact Information

Formerly Known As
Avalon Bio, Avistat Bio
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 150 Monument Road
  • Suite 207
  • Bala Cynwyd, PA 19004
  • United States
+1 (267)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 150 Monument Road
  • Suite 207
  • Bala Cynwyd, PA 19004
  • United States
+1 (267)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SwanBio Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 25-Jun-2024 Completed Generating Revenue
3. Later Stage VC 04-Oct-2023 Completed Generating Revenue
2. Later Stage VC (Series B) 08-May-2022 $56M $133M Completed Generating Revenue
1. Early Stage VC (Series A) 23-Apr-2020 $77M $77M Completed Generating Revenue
To view SwanBio Therapeutics’s complete valuation and funding history, request access »

SwanBio Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SwanBio Therapeutics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mass General Brigham Ventures Venture Capital Minority
Syncona Venture Capital Minority
To view SwanBio Therapeutics’s complete investors history, request access »

SwanBio Therapeutics FAQs

  • When was SwanBio Therapeutics founded?

    SwanBio Therapeutics was founded in 2017.

  • Where is SwanBio Therapeutics headquartered?

    SwanBio Therapeutics is headquartered in Bala Cynwyd, PA.

  • What is the size of SwanBio Therapeutics?

    SwanBio Therapeutics has 32 total employees.

  • What industry is SwanBio Therapeutics in?

    SwanBio Therapeutics’s primary industry is Drug Discovery.

  • Is SwanBio Therapeutics a private or public company?

    SwanBio Therapeutics is a Private company.

  • What is SwanBio Therapeutics’s current revenue?

    The current revenue for SwanBio Therapeutics is .

  • How much funding has SwanBio Therapeutics raised over time?

    SwanBio Therapeutics has raised $143M.

  • Who are SwanBio Therapeutics’s investors?

    Mass General Brigham Ventures and Syncona have invested in SwanBio Therapeutics.

  • When was SwanBio Therapeutics acquired?

    SwanBio Therapeutics was acquired on 25-Jun-2024.

  • Who acquired SwanBio Therapeutics?

    SwanBio Therapeutics was acquired by Spur Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process